Related Experiment Video
Updated: Mar 23, 2026

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Emerging Roles of Epigenetic Regulator Sin3 in Cancer
N Bansal1, G David2, E Farias1
1The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Abstract:
Revolutionizing treatment strategies is an urgent clinical need in the fight against cancer. Recently the scientific community has recognized chromatin-associated proteins as promising therapeutic candidates. However, there is a need to develop more targeted epigenetic inhibitors with less toxicity. Sin3 family is one such target which consists of evolutionary conserved proteins with two paralogues Sin3A and Sin3B. Sin3A/B are global transcription regulators that provide a versatile platform for diverse chromatin-modifying activities. Sin3 proteins regulate key cellular functions that include cell cycle, proliferation, and differentiation, and have recently been implicated in cancer pathogenesis. In this chapter, we summarize the key concepts of Sin3 biology and elaborate the recent advancements in the role of Sin3 proteins in cancer with specific examples in multiple endocrine neoplasia type 2, pancreatic ductal adenocarcinoma, and triple negative breast cancer. Finally, a program to create an integrative approach for screening antitumor agents that target chromatin-associated factors like Sin3 is presented.
Insights
Targeting Sin3 proteins, which regulate gene transcription, offers a promising strategy for developing novel cancer therapies. Research highlights their role in various cancers and proposes new screening methods for Sin3-targeting antitumor agents.
Area of Science:
- Epigenetics and Molecular Biology
- Cancer Pathogenesis and Therapeutics
Background:
- Chromatin-associated proteins are emerging as critical targets for innovative cancer treatments.
- There is a pressing need for targeted epigenetic inhibitors with improved safety profiles.
- The Sin3 family (Sin3A/B) comprises conserved global transcription regulators involved in essential cellular functions and implicated in cancer.
Purpose of the Study:
- To review the fundamental biology of Sin3 proteins.
- To summarize recent findings on the role of Sin3 proteins in cancer development.
- To present a novel strategy for screening anticancer agents targeting chromatin-associated factors like Sin3.
Main Methods:
- Literature review of Sin3 biology and its role in cancer.
- Analysis of Sin3 protein involvement in specific cancer types (MEN2, PDAC, TNBC).
- Proposal of an integrative screening program for chromatin-associated factor-targeting agents.
Main Results:
- Sin3 proteins are global transcription regulators influencing cell cycle, proliferation, and differentiation.
- Sin3 proteins play a significant role in the pathogenesis of multiple endocrine neoplasia type 2, pancreatic ductal adenocarcinoma, and triple-negative breast cancer.
- An integrative approach for screening Sin3-targeting antitumor agents has been proposed.
Conclusions:
- Sin3 proteins represent a promising therapeutic target for cancer treatment.
- Targeted inhibition of Sin3A/B may offer a strategy for developing novel, less toxic anticancer drugs.
- The proposed screening program aims to accelerate the discovery of effective Sin3-targeting agents.
More Related Videos
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Master Transcription Regulators
Negative Regulator Molecules
Abnormal Proliferation

